ResMed's Chief Medical Officer has suggested doctors will prescribe using both drugs and devices such as his company makes together to help sleep apnea suffers. Shares of ResMed (RMD) and Inspire ...

Inspire Medical Systems released preliminary results indicated second-quarter and full-year revenue above analysts' estimates. The sleep apnea device maker expects second quarter sales to be 30% ...

For treatment resistant cases a surgical device called Inspire (hypoglossal nerve surgery ... Researchers have been on the hunt for new ways to treat sleep apnea and prevent its complications.

The company develops minimally invasive solutions for patients with obstructive sleep apnea (OSA ... wouldn’t be good candidates for Inspire’s device, which is designed to prevent airway ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $231.12, a high ...

Obstructive Sleep Apnea affects 1 in 15 Americans, likely more, and treatment has often involved inconvenient treatments like CPAP machines. A new device called Inspire offers new alternatives for ...

Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.

The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...

Sleep studies diagnose sleep apnea. Treatments include dental devices and wearables. Screening for sleep apnea is important in diabetes detection programs. Consult a doctor if you have sleep problems.

The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...